Citigroup’s Esperion Therapeutics ESPR Stock Holding History

Citigroup’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$475K	Buy	+173,500	New	+$549K	﹤0.01%	3580
2025 Q1	–	Sell	-127,800	Closed	-$281K	–	5691
2024 Q4	$281K	Hold	127,800	–	–	﹤0.01%	4188
2024 Q3	$211K	Hold	127,800	–	–	﹤0.01%	4307
2024 Q2	$284K	Sell	127,800 -72,200	-36%	-$170K	﹤0.01%	3712
2024 Q1	$536K	Buy	200,000 +197,300	+7,307%	+$479K	﹤0.01%	3518
2023 Q4	$8.07K	Buy	+2,700	New	+$3.5K	﹤0.01%	5244
2021 Q1	–	Sell	-37,300	Closed	-$970K	–	6571
2020 Q4	$970K	Sell	37,300 -700	-2%	-$21K	﹤0.01%	3567
2020 Q3	$1.41M	Buy	38,000 +5,900	+18%	+$234K	﹤0.01%	2967
2020 Q2	$1.65M	Buy	32,100 +6,700	+26%	+$280K	﹤0.01%	3025
2020 Q1	$801K	Sell	25,400 -14,300	-36%	-$755K	﹤0.01%	3405
2019 Q4	$2.37M	Buy	39,700 +5,900	+17%	+$265K	﹤0.01%	2800
2019 Q3	$1.24M	Buy	33,800 +7,700	+30%	+$305K	﹤0.01%	3394
2019 Q2	$1.21M	Buy	26,100 +15,500	+146%	+$728K	﹤0.01%	3405
2019 Q1	$426K	Sell	10,600 -7,300	-41%	-$327K	﹤0.01%	4351
2018 Q4	$823K	Buy	17,900 +2,600	+17%	+$125K	﹤0.01%	3596
2018 Q3	$679K	Sell	15,300 -2,800	-15%	-$129K	﹤0.01%	3910
2018 Q2	$709K	Buy	18,100 +7,200	+66%	+$364K	﹤0.01%	3723
2018 Q1	$788K	Buy	10,900 +6,700	+160%	+$492K	﹤0.01%	3488
2017 Q4	$277K	Sell	4,200 -2,900	-41%	-$156K	﹤0.01%	4733
2017 Q3	$356K	Sell	7,100 -1,100	-13%	-$53K	﹤0.01%	4456
2017 Q2	$379K	Sell	8,200 -7,400	-47%	-$272K	﹤0.01%	4242
2017 Q1	$551K	Buy	15,600 +3,200	+26%	+$73.3K	﹤0.01%	3788
2016 Q4	$155K	Buy	12,400 +7,800	+170%	+$92.9K	﹤0.01%	5488
2016 Q3	$64K	Sell	4,600 -4,000	-47%	-$45.3K	﹤0.01%	5499
2016 Q2	$85K	Sell	8,600 -600	-7%	-$9.94K	﹤0.01%	5210
2016 Q1	$156K	Buy	9,200 +8,000	+667%	+$129K	﹤0.01%	5318
2015 Q4	$27K	Sell	1,200 -1,600	-57%	-$40.4K	﹤0.01%	6324
2015 Q3	$66K	Buy	+2,800	New	+$176K	﹤0.01%	5245